CIK 0001714899 · Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463872213
- Phone
- (650) 866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- 4 Open-market sale Director sold 1,666 shares at an average $52.81 ($87,983)
- 4 Open-market sale COO and Secretary sold 10,000 shares at an average $52.84 ($528,404)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale President and CEO sold 18,333 shares at an average $49.76 ($912,176)
- 4 Open-market sale Director sold 1,666 shares at $50.05 ($83,383)
- 4 Open-market sale COO and Secretary sold 10,000 shares at an average $50.56 ($505,605)
- 4 Open-market sale President and CEO sold 18,333 shares at an average $50.38 ($923,550)
- 4 Option exercise COO and Secretary acquired 9,045 shares (option exercise)
- 4 Open-market sale Director sold 1,666 shares at an average $53.40 ($88,969)
- 4 Open-market sale COO and Secretary sold 10,000 shares at an average $55.55 ($555,485)
- 4 Open-market sale President and CEO sold 18,333 shares at an average $54.66 ($1,002,012)
- 4 Open-market sale Chief Medical Officer sold 6,143 shares at $48.91 ($300,454)
- 4 Open-market sale Chief Medical Officer sold 2,546 shares at an average $49.58 ($126,230)
- 4 Open-market sale COO and Secretary sold 2,544 shares at an average $49.60 ($126,186)
- 4 Open-market sale President and CEO sold 2,376 shares at an average $49.57 ($117,769)
- 4 Open-market sale CFO and Treasurer sold 2,285 shares at an average $49.57 ($113,263)
- 4 Open-market sale Director sold 1,666 shares at an average $51.70 ($86,139)
- 4 Open-market sale COO and Secretary sold 10,000 shares at an average $52.22 ($522,233)
- 4 Open-market sale President and CEO sold 18,333 shares at an average $51.41 ($942,477)
Page 22 of 40 · 789 filings